S Mahmud

Summary

Affiliation: McGill University
Country: Canada

Publications

  1. ncbi Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis
    S Mahmud
    Department of Oncology, McGill University, Gerald Bronfman Centre, 546 Pine Avenue West, Montreal, Quebec, Canada
    Br J Cancer 90:93-9. 2004
  2. ncbi Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis
    Salaheddin M Mahmud
    Department of Oncology, McGill University, Montreal, Quebec, Canada
    Int J Cancer 127:1680-91. 2010
  3. ncbi Antidepressants and risk of prostate cancer: a nested case-control study
    H M Tamim
    Center for Clinical Epidemiology and Community Studies, Lady Davis Institute for Medical Research, Montreal, Quebec, Canada
    Prostate Cancer Prostatic Dis 11:53-60. 2008

Collaborators

  • J A Hanley
  • H M Tamim
  • J F Boivin
  • J P Collet
  • J-F Boivin
  • M R Stang
  • J-P Collet

Detail Information

Publications3

  1. ncbi Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis
    S Mahmud
    Department of Oncology, McGill University, Gerald Bronfman Centre, 546 Pine Avenue West, Montreal, Quebec, Canada
    Br J Cancer 90:93-9. 2004
    ..The current epidemiological evidence and, in particular, the strong and consistent laboratory evidence underline the need for additional epidemiological studies to confirm the direction and magnitude of the association...
  2. ncbi Use of nonsteroidal anti-inflammatory drugs and prostate cancer risk: a meta-analysis
    Salaheddin M Mahmud
    Department of Oncology, McGill University, Montreal, Quebec, Canada
    Int J Cancer 127:1680-91. 2010
    ..There is a need for well-designed observational studies with adequate exposure measurements, accurate case definition, attention to latency effects, and careful adjustment for screening and other biases...
  3. ncbi Antidepressants and risk of prostate cancer: a nested case-control study
    H M Tamim
    Center for Clinical Epidemiology and Community Studies, Lady Davis Institute for Medical Research, Montreal, Quebec, Canada
    Prostate Cancer Prostatic Dis 11:53-60. 2008
    ..TCA use 2-5 years in the past was associated with a small dose-dependent increase in the risk of prostate cancer. Nevertheless, detection bias could have contributed to the observed association...